You are here: All Products  > Transcenta Cleared to Proceed in a US Phase III Trial of CLDN18.2 Antibody

Transcenta Cleared to Proceed in a US Phase III Trial of CLDN18.2 Antibody

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products